TGFBR1-IN-1
Ponsegromab
Bimagrumab
Elezanumab
Trevogrumab
Landogrozumab
Metelimumab
Carotuximab
Taldefgrobep alfa
Cirevetmab
Bintrafusp alfa
Apitegromab
Stamulumab
Sotatercept
Luspatercept
Livmoniplimab
Lerdelimumab
Garetosmab
Nadecnemab
Ramatercept